SpyBiotech
Mark Leuchtenberger is Chief Executive Officer at SpyBiotech. Mark has a history of c-suite company leadership, including Chairman positions at Neurosense Therapeutics and Aleta Biotherapeutics, as well as President & CEO roles at IRX Therapeutics and Chiasma. He attended Wake Forest University and the Yale School of Management.
This person is not in any offices
SpyBiotech
1 followers
SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases.